Allos Ventures is pleased to announce the final closing of Allos II, a $40 million venture capital fund targeting investments in early-stage technology companies in the Midwest. Allos II is led by Don Aquilano, John McIlwraith, and Dov Rosenberg and builds on the success of our first fund, which invested in AssureRx Health BidPal Networks, Scale Computing, and Weblink International.
The investment strategy of Allos II continues the successful Allos I strategy, including:
Industry Focus. Companies in high-growth sectors where the managing directors have operating and investing experience - primarily software and technology-enabled business services, but also specialty healthcare providers, later-stage medical devices and diagnostics, and advanced manufacturing. No pharmaceutical or biotechnology companies.
To read the full, original article click on this link:
